
10-11 May 2018, Boston, USA
Following on from its huge success in 2017, Oxford Global are proud to present their
2nd Annual Advances in Trangsgenic Technology USA Congress, 10-11 May, Boston, USA. This event will host over 300 delegates from the leading research & academic institutions and clinical research in the USA as well as leading pharma
ceutical and Biotech companies from around the globe.
World renowned experts will give over 20 presentations across 2 interactive streams, including:
▪ Technical Advances in Transgenic Genome Editing
▪ Transgenic Models of Disease and Therapeutic Applications
Presentations will focus on key issues in transgenic technologies including in-vivo CRISPR genome editing, translational applications using various animal models and transgenic models of oncology, cardiovascular disease and metabolic disorders.
Free Pre-Congress Live Webinar
Latest CRISPR Genome Editing and Thereapeutic Applications of Mouse and Rat Models
Chengyu Liu, Core Director, Transgenic Core, National Heart, Lung, and Blood and Shanrong Zhao, Director Computational Biology and Bioinformatics, Pfizer